Skip to main content

Agora
Sign in

House bill · H.R. 2343 (119th Congress)

John W. Walsh Alpha-1 Home Infusion Act of 2025

U.S. House of Representatives

Latest action Dec 18, 2025

Sponsor: Maria Elvira Salazar (U.S. Representative, FL-27, Republican)

Follow

Following needs an Agora account. You will sign in first, then come back to this page.

From Congress.gov and official rosters. This record was last updated Jul 30, 2026. About our data

Summary

John W. Walsh Alpha-1 Home Infusion Act of 2025 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.

Summary from the Congressional Research Service. How we handle summaries

Where it stands

Assigned to a committee for review.

  1. Introduced
  2. In committee
  3. Up for a vote
  4. Passed one chamber
  5. Passed
  6. Enacted

Committee

House Committee on Energy and Commerce · U.S. House of Representatives

Also referred to House Committee on Ways and Means · U.S. House of Representatives.

Your position on this bill

Choose the position closest to yours. You'll sign in or create an account to save it.

Sign in or create an account to give your position

Cosponsors

55

Showing the 54 who are on Agora, A to Z. Congress.gov listed 55 as of Jul 30, 2026.

See all cosponsors on Congress.gov (opens in a new tab)
  • Democratic33
  • Republican21

This bill has cosponsors from more than one party.

Party is shown for the 54 cosponsors who are on Agora.

Shown in neutral colors by design; Agora is non-partisan.

Show the full list (54 names)

Full history

  1. Dec 18, 2025

    Introduced

    Introduced in U.S. House

    U.S. House

  2. Mar 25, 2025

    Introduced

    Introduced in House

    U.S. House of Representatives

  3. Mar 25, 2025

    In committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

    U.S. House

  4. Mar 25, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

  5. Mar 25, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Show full history (1 earlier event)
  1. Mar 25, 2025

    Referred to committee

    Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Read the record